HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The peptide AF-16 and the AF protein counteract intracranial hypertension.

Abstract
Intracranial hypertension develops after, for example, trauma, stroke and brain inflammation, and contributes to increased morbidity, mortality, and persistent neuropsychiatric sequelae. Nonsurgical therapy offers limited relief. We investigated whether the peptide AF-16 and the endogenous protein Antisecretory Factor (AF) counteracted abnormal fluid transfer by cells, and lowered raised intracranial pressure (ICP). Adult rats, infected with an encephalitogenic Herpes simplex virus (HSV-1), developed after 5 days' sickness of increasing severity. AF-16 rescued all rats while vehicle treatment only saved 20%. AF-16 from day 4 reduced the ICP in HSV-1-infected rats from 30.7 to 14.6 mmHg and all survived without sequelae. A standardised closed head brain injury in rats raised the ICP. Continuous and intermittent AF-16 kept ICP at an almost normal level. A single dose of AF-16 maintained the raised ICP after a TBI lowered during 3-9 h. The AF protein, enriched in egg yolk, similarly lowered the post-traumatically raised ICP in rats. AF-16 also lowered the ICP in rabbits with diffuse brain injury. We conclude that the peptide AF-16 and the AF protein offer new approaches to treat raised ICP with no side effects.
AuthorsHans-Arne Hansson, Mohamed Al-Olama, Eva Jennische, Kliment Gatzinsky, Stefan Lange
JournalActa neurochirurgica. Supplement (Acta Neurochir Suppl) Vol. 114 Pg. 377-82 ( 2012) ISSN: 0065-1419 [Print] Austria
PMID22327727 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Neuropeptides
  • Peptides
  • antisecretory factor
  • peptide AF-16
Topics
  • Animals
  • Brain Injuries (complications)
  • Disease Models, Animal
  • Female
  • Herpes Simplex (complications)
  • Herpesvirus 1, Human
  • Intracranial Hypertension (drug therapy, etiology, virology)
  • Intracranial Pressure (drug effects, physiology)
  • Male
  • Neuropeptides (metabolism, therapeutic use)
  • Peptides (therapeutic use)
  • Rabbits
  • Rats

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: